Mannveet Dhillon, PA
Physician Assistant · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
Offices
4 locations · Carbon Health Medical Group of California PC · 335 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Mannveet Dhillon’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- Illinois 085008334Licensed Physician Assistant · since 2021 · expires 2024-03-01Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$8,860
Medicare paid this office $8,860 for 86 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 29 | $2,567 | $83 |
| New patient visit (45+ min) | 23 | $2,424 | $105 |
| New patient visit (30+ min) | 14 | $1,103 | $79 |
| Short return visit (20+ min) | 20 | $873 | $42 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 13 | $527 | $41 |
See all 7 services
| Return visit (30+ min) | 29 | $2,567 | $83 |
| New patient visit (45+ min) | 23 | $2,424 | $105 |
| New patient visit (30+ min) | 14 | $1,103 | $79 |
| Short return visit (20+ min) | 20 | $873 | $42 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 13 | $527 | $41 |
| Detection test by immunoassay with direct visual observation for influenza virus | 13 | $406 | $16 |
| Automated urinalysis test | 13 | $29 | $2 |
Who their Medicare patients are
86 Original Medicare patients in 2024. Average age 69 · Women 71% · Also on Medicaid 20% · Health risk score 0.80. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 48% · Depression 21% · Diabetes 16% · Cancer 13%.
The office billed $36,616, Medicare allowed $12,719 and paid $8,860; for 179 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 86 | 179 | 69 | 0.80 | $36,616 | $8,860 |
| 2023 | 105 | 275 | 69 | 1.08 | $26,880 | $9,342 |
| 2022 | 228 | 875 | 74 | 2.44 | $132,565 | $52,653 |
| 2021 | 196 | 1,357 | 76 | 2.87 | $198,054 | $96,548 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Short return visit (20+ min) | 54 | $3,019 | $51 |
| New patient visit (30+ min) | 36 | $2,016 | $56 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 29 | $1,298 | $41 |
| Return visit (30+ min) | 11 | $964 | $74 |
| Detection test by immunoassay with direct visual observation for influenza virus | 11 | $389 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 21 | $356 | $16 |
| Automated urinalysis test | 16 | $40 | $2 |
2022: 10 services
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 135 | $28,124 | $77 |
| Transitional care management services for problem of high complexity | 17 | $3,477 | $205 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 71 | $2,061 | $25 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 20 | $1,934 | $38 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 55 | $1,861 | $32 |
| Short return visit (20+ min) | 33 | $1,814 | $52 |
| New patient visit (30+ min) | 22 | $1,538 | $70 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 36 | $1,460 | $41 |
| Detection test by immunoassay with direct visual observation for influenza virus | 20 | $649 | $16 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; booster dose | 11 | $458 | $42 |
2021: 13 services
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 165 | $59,906 | $93 |
| Transitional care management services for problem of high complexity | 24 | $5,439 | $201 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 46 | $5,405 | $30 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $4,436 | $120 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 90 | $3,679 | $30 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 83 | $3,452 | $38 |
| Residence visit for new patient with moderate level of medical decision making, per day at least 60 minutes | 22 | $2,861 | $130 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 41 | $2,074 | $44 |
| Transitional care management services for problem of at least moderate complexity | 11 | $1,637 | $149 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 18 | $576 | $32 |
| Administration of influenza virus vaccine | 30 | $538 | $18 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 11 | $462 | $42 |
| Influenza vaccine, quadrivalent derived from cell cultures | 12 | $340 | $28 |
Medicaid work
$88,107 in 2024
Medicaid paid $88,107 for 3,295 billed services this clinician did in 2024, up to 127 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 495 | $27,295 |
| Short return visit (20+ min) | 366 | $13,192 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 387 | $12,406 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 56 | $9,725 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 888 | $8,440 |
| New patient visit (45+ min) | 109 | $6,551 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 467 | $4,571 |
| New patient visit (30+ min) | 93 | $4,118 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 296 | $359 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 24 | $358 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe technique | 15 | $340 |
| Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique | 13 | $291 |
| 2024 | 3,295 | 15 | 127 | $88,107 |
| 2023 | 4,886 | 10 | 121 | $128,075 |
| 2022 | 343 | 4 | 27 | $8,712 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,275 | $44,918 |
| Return visit (30+ min) | 494 | $25,836 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 597 | $19,761 |
| New patient visit (30+ min) | 421 | $19,010 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 693 | $7,082 |
| New patient visit (45+ min) | 74 | $5,399 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 318 | $3,083 |
| Service(s) provided in the office during regularly scheduled evening, weekend, or holiday office hours, in addition to basic service | 766 | $2,573 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 226 | $308 |
| URINE PREGNANCY TEST | 22 | $106 |
2022
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 88 | $3,271 |
| Short return visit (20+ min) | 105 | $3,271 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 136 | $1,492 |
| Return visit (30+ min) | 14 | $678 |
Drugs they prescribed that Part D paid
$1,567
Pharmacies billed $1,567 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 166) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
157 generic and fewer than 11 brand-name prescriptions · $1,567 in drug cost · 88 antibiotic prescriptions to 78 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 30 | $224 | $7 |
Year by year
| 2024 | 166 | 114 | 0% (0) | None | $1,567 |
| 2023 | 419 | 257 | 0% (0) | None | $18,808 |
| 2022 | 2,144 | 297 | 4% (75) | 15% | $182,091 |
| 2021 | 1,232 | 134 | 6% (68) | 13% | $85,192 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Amoxicillin-Clavulanate Potass | 69 | $578 | $8 |
| Methylprednisolone | 46 | $364 | $8 |
| Albuterol Sulfate Hfa | 12 | $345 | $29 |
| Nitrofurantoin Mono-Macro | 25 | $321 | $13 |
| Doxycycline Hyclate | 15 | $236 | $16 |
| Fluticasone Propionate | 19 | $214 | $11 |
| Azithromycin | 29 | $109 | $4 |
| Cephalexin | 16 | $106 | $7 |
| Sulfamethoxazole-Trimethoprim | 15 | $105 | $7 |
| Ciprofloxacin | 15 | $94 | $6 |
2022: 58 drugs
| Eliquis | 33 | $29,196 | $885 |
| Symbicort | 32 | $17,430 | $545 |
| Advair Diskus | 15 | $11,849 | $790 |
| Restasis Multidose | 11 | $7,653 | $696 |
| Novolin 70-30 | 12 | $7,184 | $599 |
| Levemir Flextouch | 12 | $6,130 | $511 |
| Lantus Solostar | 17 | $5,017 | $295 |
| Albuterol Sulfate Hfa | 58 | $3,420 | $59 |
| Ventolin Hfa | 29 | $3,239 | $112 |
| Diclofenac | 38 | $1,369 | $36 |
| Nifedipine Er | 13 | $1,219 | $94 |
| Duloxetine | 13 | $1,094 | $84 |
| Atorvastatin | 91 | $1,028 | $11 |
| Amlodipine Besylate | 102 | $1,009 | $10 |
| Potassium Chloride | 43 | $993 | $23 |
| Hydrocodone-Acetaminophen | 38 | $936 | $25 |
| Gabapentin | 47 | $871 | $19 |
| Donepezil | 18 | $710 | $39 |
| Omeprazole | 33 | $561 | $17 |
| Lisinopril | 47 | $517 | $11 |
| Enalapril Maleate | 19 | $507 | $27 |
| Pantoprazole | 34 | $462 | $14 |
| Hydralazine | 29 | $442 | $15 |
| Carvedilol | 24 | $431 | $18 |
| Methylprednisolone | 52 | $429 | $8 |
| Metoprolol | 30 | $429 | $14 |
| Famotidine | 14 | $413 | $29 |
| Buspirone | 14 | $411 | $29 |
| Losartan-Hydrochlorothiazide | 11 | $348 | $32 |
| Metformin | 51 | $339 | $7 |
| Azithromycin | 49 | $334 | $7 |
| Fluticasone Propionate | 28 | $330 | $12 |
| Levetiracetam | 11 | $309 | $28 |
| Hydroxyzine | 11 | $299 | $27 |
| Clopidogrel | 14 | $287 | $21 |
| Levothyroxine | 17 | $285 | $17 |
| Amoxicillin-Clavulanate Potass | 30 | $284 | $9 |
| Allopurinol | 21 | $263 | $13 |
| Nitrofurantoin Mono-Macro | 20 | $259 | $13 |
| Metoprolol | 47 | $252 | $5 |
| Losartan | 27 | $246 | $9 |
| Clonidine | 17 | $244 | $14 |
| Furosemide | 52 | $242 | $5 |
| Warfarin | 18 | $223 | $12 |
| Glipizide Er | 26 | $213 | $8 |
| Trazodone | 19 | $184 | $10 |
| Tramadol | 28 | $172 | $6 |
| Alprazolam | 11 | $126 | $11 |
| Doxycycline Hyclate | 12 | $123 | $10 |
| Spironolactone | 13 | $122 | $9 |
| Prednisone | 40 | $113 | $3 |
| Glipizide | 22 | $101 | $5 |
| Hydrochlorothiazide | 28 | $95 | $3 |
| Simvastatin | 13 | $87 | $7 |
| Lovastatin | 11 | $84 | $8 |
| Cephalexin | 12 | $75 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $55 | $3 |
| Ciprofloxacin | 11 | $42 | $4 |
2021: 36 drugs
| Symbicort | 12 | $7,931 | $661 |
| Albuterol Sulfate Hfa | 26 | $1,481 | $57 |
| Diclofenac | 33 | $1,360 | $41 |
| Hydrocodone-Acetaminophen | 40 | $1,152 | $29 |
| Amlodipine Besylate | 83 | $814 | $10 |
| Nifedipine Er | 13 | $791 | $61 |
| Atorvastatin | 48 | $787 | $16 |
| Gabapentin | 36 | $755 | $21 |
| Potassium Chloride | 25 | $481 | $19 |
| Metoprolol | 20 | $435 | $22 |
| Omeprazole | 25 | $410 | $16 |
| Pantoprazole | 23 | $393 | $17 |
| Nitrofurantoin | 11 | $390 | $35 |
| Levothyroxine | 17 | $334 | $20 |
| Famotidine | 13 | $310 | $24 |
| Allopurinol | 19 | $294 | $15 |
| Losartan | 18 | $271 | $15 |
| Furosemide | 45 | $254 | $6 |
| Enalapril Maleate | 11 | $252 | $23 |
| Lisinopril | 27 | $240 | $9 |
| Glipizide Er | 14 | $233 | $17 |
| Metoprolol | 20 | $212 | $11 |
| Triamcinolone Acetonide | 20 | $191 | $10 |
| Carvedilol | 17 | $188 | $11 |
| Hydralazine | 15 | $177 | $12 |
| Montelukast | 11 | $171 | $16 |
| Clonidine | 19 | $165 | $9 |
| Fluticasone Propionate | 11 | $160 | $15 |
| Alprazolam | 13 | $148 | $11 |
| Metformin | 33 | $139 | $4 |
| Warfarin | 14 | $120 | $9 |
| Trazodone | 13 | $93 | $7 |
| Tramadol | 17 | $92 | $5 |
| Prednisone | 13 | $40 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $40 | $3 |
| Glipizide | 12 | $40 | $3 |
Money from drug and device companies
$117 in 2024
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $117 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Meals · 2024-05-28 | Airsupra | $117 |
Professional record
- NPI
- 1992373401
- Licence
- IL 085.008334Illinois 085008334: Not Renewed
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1355 Remington Rd Ste H, Schaumburg, IL, 60173
- NPI first listed
- 2021-06-12
- NPI last updated
- 2021-06-12
- NPI record certified
- 2021-06-10
This is when the NPI record was last certified, not a medical board exam.